Gaps in healthcare for individuals with Parkinson’s disease in the U.S. have been identified, with notable disparities observed for…
Articles by Margarida Maia, PhD
The U.S. Food and Drug Administration (FDA) has approved Boston Scientific’s software called Vercise Neural Navigator 5, which provides visual…
Imaging software developed by Braintale may distinguish Parkinson’s disease from atypical parkinsonism based on measures of…
Using a smartwatch to track how fast people can move may help identify who’s at risk for Parkinson’s disease…
The Center for Movement Disorders and Neurorestoration at the University of California (UC) Davis Health Department of Neurology will…
BrainTale raised €4.5 million (about $5 million) to speed further development of software that can decode changes in the…
UB-312, an experimental vaccine by Vaxxinity, appeared safe and well tolerated and was able to produce an immune response against…
Axial Therapeutics will use a new research grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF)…
People with Parkinson’s disease who are experiencing cognitive decline may show weaker low-frequency brain waves on an electroencephalogram (EEG),…
A grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) will allow Icometrix — a company focused…